Effects of Exercise Intervention and Confounding Factors on Type II Diabetic Muscles

December 21, 2020 updated by: National Taiwan University Hospital
The aim of the first year of this three-year plan is to analyze and compare the muscle quality of lower limb muscle (microcirculation, muscle performance and mechanical characteristics) and maximal aerobic exercise capacity in treadmill exercise tests for diabetic and non-diabetic cases. The hypotheses are:1) the muscle quality of lower limb muscle and maximal aerobic exercise capacity are different between participate with diabetic and non-diabetic, 2) the effect of the three-month aerobic exercise intervention or home exercise on the characteristics of the muscle quality are different , and 3) intrinsic factors (such as age, BMI, and HDL) and characteristics of specific FTO genes are influenced the training outcomes.

Study Overview

Detailed Description

Participants with diabetes will attend an 12-week aerobic exercise intervention or home exercise if the exercise test result of the maximum rate of oxygen consumption is fair or poor. Assessments will be taken before and after the training program, which including muscle strength, stiffness, quality, microcirculation and exercise capacity. Comparisons between the pre-training and post-training condition will be made for each groups. And the assessments also compare with the healthy control group.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 100
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diabetes group: 1) Age between 30-70 years of old, 2) type 2 diabetes.
  • Healthy control group: 1) Age between 30-70 years of old, 2) without diabetes

Exclusion Criteria:

  • history of moderate-severe somatic or autonomic neuropathy, cardiovascular disease, preproliferative or proliferative retinopathy, and chronic renal failure
  • unable to perform the programs or assessments
  • other systematic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: aerobic exercise group
This study will recruit qualified diabetic subjects according to their results of maximal aerobic exercise capacity (VO2max) and assign them into aerobic exercise or home exercise groups, based on their willingness. The aerobic exercise group will arranged to the supervised aerobic dance program, it's consisted of 50 mins per session, 3 sessions per week and last for 3 months.

The aerobic exercise and home exercise programs are consisted of 50 minutes per time, 3 times per weeks and totally 3 months.

The aerobic exercise group will perform the exercise program under one physical therapy and one aerobic dance teacher supervised. The home exercise group will do the exercise program based on ACSM's aerobic exercise recommend, and will used the home exercise record form to make sure their cooperation.

EXPERIMENTAL: home exercise group
This study will recruit qualified diabetic subjects according to their results of maximal aerobic exercise capacity (VO2max) and assign them into aerobic exercise or home exercise groups, based on their willingness.The home exercise group will give the exercise recommendation based on ACSM's guideline, and it's consisted of 50 mins per session, 3 sessions per week and last for 3 months.

The aerobic exercise and home exercise programs are consisted of 50 minutes per time, 3 times per weeks and totally 3 months.

The aerobic exercise group will perform the exercise program under one physical therapy and one aerobic dance teacher supervised. The home exercise group will do the exercise program based on ACSM's aerobic exercise recommend, and will used the home exercise record form to make sure their cooperation.

ACTIVE_COMPARATOR: health control group
This study will recruit subjects without type 2 diabetes and the age matched to the diabetes groups.

The aerobic exercise and home exercise programs are consisted of 50 minutes per time, 3 times per weeks and totally 3 months.

The aerobic exercise group will perform the exercise program under one physical therapy and one aerobic dance teacher supervised. The home exercise group will do the exercise program based on ACSM's aerobic exercise recommend, and will used the home exercise record form to make sure their cooperation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
index of muscle stiffness
Time Frame: Change from Baseline muscle quality at 3 months
elastography was used, units on kPa
Change from Baseline muscle quality at 3 months
muscle strength of knee extensor and plantarflexor
Time Frame: Change from Baseline functional performance at 3 months
Dynamometer was used to measure muscle strength, units on kilograms
Change from Baseline functional performance at 3 months
Relative sliding of muscles
Time Frame: Change from Baseline muscle quality at 3 months
B mode sonography was used, units on mm/s
Change from Baseline muscle quality at 3 months
muscle microcirculation
Time Frame: Change from Baseline muscle quality at 3 months
Near-infrared spectroscopy was used to measure oxygen saturation on muscle, units on percentage
Change from Baseline muscle quality at 3 months
maximum rate of oxygen consumption
Time Frame: Baseline
Bruce treadmill protocol was used in the maximal exercise testing, maximum rate of oxygen consumption record as ml/kg/min
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
characteristics of specific FTO genes
Time Frame: Baseline
rs9939609 SNP analysis, record as TT or TA or AA type
Baseline
physical activity level
Time Frame: Change from Baseline functional performance at 3 months
self report the ability of walking one-fourth of a mile, record as degree of difficulty: none, some difficulty, much difficulty, inability
Change from Baseline functional performance at 3 months
BMI
Time Frame: Change from Baseline functional performance at 3 months
weight and height will be combined to report BMI in kg/m^2
Change from Baseline functional performance at 3 months
blood glucose level
Time Frame: Change from Baseline functional performance at 3 months
Hemoglobin A1c (HbA1c), unit on percentage
Change from Baseline functional performance at 3 months
blood cholesterol
Time Frame: Change from Baseline functional performance at 3 months
total cholesterol, units on mg/dL
Change from Baseline functional performance at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 15, 2019

Primary Completion (ACTUAL)

May 31, 2020

Study Completion (ACTUAL)

July 31, 2020

Study Registration Dates

First Submitted

March 5, 2019

First Submitted That Met QC Criteria

March 8, 2019

First Posted (ACTUAL)

March 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 23, 2020

Last Update Submitted That Met QC Criteria

December 21, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 201812135RINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes and Healthy Control

Clinical Trials on supervised aerobic exercise or home-based aerobic exercise

3
Subscribe